drugset / Trial / NCT01791920
To Evaluate the Safety and Efficacy of Botulax® Are Not Inferior to Those of Botox® in the Treatment of Glabellar Lines
RandomizedParallel-groupDouble-blindTreatment
Summary
To compare the safety and efficacy of Botulax® with Botox® in the improvement of moderate to severe glabellar lines.
Timeline
- Start
- 2011-08
- Primary completion
- 2011-12
- Completion
- 2012-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Botulinum toxin type A | Protein / enzyme biologic | 20 iu | — |
| Comparator | letibotulinumtoxinA | Protein / enzyme biologic | 20 iu | — |